MOLLY MONROE: Open Payments
NPI 1598472136 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 47 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $1,275
Food & beverage: $1,276
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $269 |
| Janssen Biotech, Inc. | 4 | $188 |
| ABBVIE INC. | 14 | $180 |
| Incyte Corporation | 2 | $158 |
| Lilly USA, LLC | 8 | $153 |
| Regeneron Healthcare Solutions, Inc. | 2 | $144 |
| LEO Pharma Inc. | 2 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $48 |
| GENZYME CORPORATION | 1 | $27 |
| Amgen Inc. | 1 | $23 |
Products named: Bimzelx, TREMFYA, OPZELURA, SKYRIZI, LIBTAYO, TALTZ, EBGLYSS, ADBRY.
Industry payments across IA — which companies pay providers there.
